SIBO Testing Is Unreliable – Here’s What to Assess Instead
August 4, 2026
If you work with patients who have bloating, abdominal discomfort, constipation, diarrhea, or a digestive system that never seemed to recover after food poisoning, the possibility of SIBO has probably crossed your mind And at some point, you may have thought that the logical test would be a lactulose or glucose breath test to confirm your suspicions.
But unfortunately, they don’t. These tests can provide limited information, but neither one is definitive – and the lactulose test is especially vulnerable to being influenced by intestinal transit time. A positive result can cause a premature antimicrobial protocol while the underlying reason the bacterial overgrowth happened in the first place has yet to be investigated.
This is where we need to stop. SIBO is not the whole story. It’s simply a collection of symptoms that should make you ask what failed in the patient’s normal digestive defenses, motility, anatomy, medication history, or even nervous-system regulation.
SIBO breath tests have meaningful diagnostic limitations. A lactulose breath test can read early colonic fermentation as small-intestinal overgrowth when transit time is rapid, while a glucose test may miss overgrowth farther down the small intestine because glucose is absorbed proximally. If testing is used, interpret it alongside symptoms, risk factors, medication and surgical history, motility, and the patient’s response over time – not as a stand-alone diagnosis.
SIBO Is a Location Problem – But Not the Entire Problem
SIBO stands for Small Intestinal Bacterial Overgrowth. In simple terms, microbes are present in excessive numbers or in an unfavorable pattern in the small intestine, where fermentation can produce hydrogen and contribute to bloating, distention, diarrhea, malabsorption, and discomfort. Methane is produced by archaea rather than bacteria, which is why current terminology distinguishes Intestinal Methanogen Overgrowth, or IMO, from SIBO.
I explain it this way: the organisms doing their normal job – they are just in the wrong location. Getting undressed in your bathroom makes perfect sense. Doing it on the sidewalk does not. Location changes the entire situation.
But identifying the overgrowth does not tell you why the small intestine stopped protecting and clearing itself properly. If we rush from symptoms or a positive breath test to “kill the organisms,” we may temporarily reduce the gas and bloating without changing the environment that allowed the problem to develop in the first place
How Reliable Are SIBO Breath Tests?
The honest answer is: less reliable than the lab report may make them appear.
A 2024 clinical practice update endorsed by the European Society of Neurogastroenterology and Motility and the American Neurogastroenterology and Motility Society sharply criticized the routine use of breath testing – particularly lactulose breath testing – to diagnose SIBO in patients with irritable bowel syndrome. The authors concluded that the underlying SIBO-IBS hypothesis remained unproven and warned that poorly validated testing had encouraged inappropriate antibiotic use. (Critical appraisal of the SIBO hypothesis and breath testing)
A separate systematic review and meta-analysis found substantial limitations in both commonly used tests. When compared against small-bowel aspirate culture, pooled sensitivity and specificity were approximately 42% and 70.6% for lactulose testing and 54.5% and 83.2% for glucose testing. In plain English, neither test is strong enough to function as a clinical verdict by itself. (Breath tests for the non-invasive diagnosis of SIBO)
Why the lactulose test can produce a false-positive pattern
Lactulose is not absorbed in the small intestine. It eventually reaches the colon, where bacteria ferment it and create gas – that part is expected. The interpretation problem is deciding whether an earlier rise in breath hydrogen came from the small intestine or from lactulose reaching the colon quickly.
In a patient with rapid transit time, colonic fermentation may occur inside the test’s diagnostic window, making it look like SIBO. In other words, the test may partly reflect orocecal transit rather than the location of bacterial overgrowth. Previous GI surgery can make that interpretation even more difficult.
Why the glucose test is not a perfect substitute
Glucose testing is generally more specific than lactulose testing, but glucose is absorbed in the proximal small intestine. That reduces the chance of colonic fermentation confusing the result, but it also creates a different limitation: overgrowth in the more distal small intestine may be missed.
If a patient strongly prefers breath testing and the choice is between these two substrates, I lean toward glucose because it is less prone to the transit-time problem. But I would still never let a glucose result override patient history, physiology, and the bigger clinical picture.
What about jejunal aspirate culture?
Small-bowel aspirate and culture obtained during endoscopy is often treated as the reference standard, but it is invasive, expensive, not widely available, and itself limited by sampling location, contamination risk, and inconsistent laboratory thresholds. That leaves us without one accessible, universally accepted test that cleanly answers the SIBO question.
This is exactly why solid clinical reasoning matters.
A Test Result Cannot Explain Why the Overgrowth Developed
When the patient’s symptoms and history suggest possible overgrowth, I want to know what changed. The six areas below are not a complete differential diagnosis, and the patient may have more than one. These are the areas I would investigate further before assuming a breath-test was the final diagnosis.
1. Impaired migrating motor complex activity
The migrating motor complex, or MMC, is a recurring pattern of electrical and muscular activity that helps move residual material through the stomach and small intestine during fasting. I call it the digestive housekeeping wave.
Consumption of food interrupts the fasting MMC pattern. That does not mean every snack “causes SIBO,” but constant grazing can eliminate longer fasting intervals in which these housekeeping contractions do their best work. For certain patients, meal spacing may be an important part of a broader motility strategy.
Post-infectious IBS also belongs in this conversation. After acute gastroenteritis, some patients develop antibodies associated with altered gut motility, including antibodies involving vinculin-related pathways. This is still an evolving area of research – not a universal explanation for every post-infectious digestive complaint – but a history of food poisoning or traveler’s diarrhea followed by persistent bowel changes is clinically meaningful.
Ask about the following:
- Did your digestive symptoms begin after a bout of food poisoning, traveler’s diarrhea, or a severe GI infection?
- Did you ever feel that your digestion fully returned to normal?
- Do you graze throughout the day, or do you allow 4-5 hours between meals?
- Are you experiencing constipation, slow transit, or other motility symptoms?
2. Hypothyroidism and slowed transit
Thyroid status affects gastrointestinal motility. When thyroid function is low, transit time may slow and create conditions that make microbial accumulation more likely.
An older case-control study found a positive glucose breath test in 54% of 50 patients with a history of hypothyroidism compared with 5% of controls. That association is worth noticing, but it should not be assumed as absolute proof that hypothyroidism causes SIBO in every patient, especially given the limitations of breath testing itself. (Association between hypothyroidism and SIBO)
For a patient with persistent bloating, constipation, slow transit, cold intolerance, fatigue, or a known thyroid history, I would not regard the words “my TSH was normal” as being the final verdict. Look at the markers that were actually tested, interpret them within your legal and professional scope, and refer or collaborate when a more complete medical evaluation is warranted.
3. Reduced gastric-acid defenses and acid-suppressing medication
Gastric acidity is one of the body’s primary defenses against ingested microbes. Long-term proton pump inhibitor use has been associated with SIBO in meta-analyses, although study results vary with the diagnostic method used.
Use of proton pump inhibitors, H2 blockers, antacids, and other over-the-counter acid suppressing options are prime suspects. Do not tell a patient to abruptly discontinue a prescribed acid-suppressing medication. Changes should be coordinated with the prescribing clinician because rebound acid hypersecretion and the original reason they were prescribed need to be considered.
Always assess upper-digestive function first, rather than assuming every lower-GI symptom began in the lower GI tract.
4. Structural or postsurgical changes
Adhesions, strictures, diverticula, blind loops, altered anatomy, and some abdominal surgeries can create areas of stasis or change the normal movement of intestinal contents. Any type of bowel surgery should be factored in as a possible culprit including appendectomy, cholecystectomy, C-section, or any procedure followed by a noticeable change in digestion.
But not every prior surgery is the cause. It is simply a clue that may justify further evaluation – especially when there is severe pain, vomiting, weight loss, GI bleeding, anemia, fever, progressive gut distention, or concern about possible obstruction.
5. Medications that slow intestinal transit
Opioids can markedly reduce GI motility and commonly cause constipation. Other medications may also influence transit, secretions, or the microbiome. Review the whole list rather than asking only about antibiotics.
Ask when the medication was started, whether the bowel pattern changed afterward, and whether the patient is currently taking it. All changes in medication should be referred to the prescribing clinician.
6. Chronic stress and autonomic dysregulation
Digestion is highly influenced by the health of the nervous system. Persistent sympathetic activation can affect gastric accommodation, secretion, visceral sensitivity, and motility. Stress is not a lazy explanation for symptoms and should never be used to dismiss a patient’s complaints. It is simply one mechanism that could be contributing to the problem.
Ask the patient about timing. Did their symptoms begin or worsen during prolonged grief, trauma, caregiving, sleep disruption, or relentless work stress? Do they eat while feeling rushed and distracted? Addressing their current nervous-system load does not replace a GI workup; it makes the workup more complete.
Why SIBO Often Returns After Treatment
One study following patients after rifaximin treatment found recurrent positive glucose breath tests in 12.6% at three months, 27.5% at six months, and 43.7% at nine months. Older age, appendectomy history, and chronic proton pump inhibitor use were also associated with recurrence. Those results come from one study and one treatment model, but they reinforce the larger clinical point: recurrence is common enough that eradication alone is not a durable plan. (SIBO recurrence after antibiotic therapy)
Using an antimicrobial may reduce the overgrowth. But it does not automatically restore motility, correct hypothyroidism, change altered anatomy, resolve a medication effect, or address the aftermath of gastroenteritis.
That is why I do not use a breath test as the only definition of success. Understanding their symptoms, bowel pattern, nutritional status, tolerance of food, recurrence, and the suspected underlying driver all matter. A positive test without a compatible clinical picture is suspect. A negative test does not eliminate a compelling history.
A More Useful Clinical Sequence
Start with the history – not the supplement shelf
Before you build a treatment protocol, be sure you document:
- Symptom onset and relationship to food poisoning or gastroenteritis
- Bloating timing, abdominal pain, distention, and food tolerance
- Diarrhea, constipation, or an alternating pattern
- Meal timing and constant grazing
- Thyroid symptoms, diagnoses, laboratory history, and medication
- Proton pump inhibitors, H2 blockers, antacids, opioids, and other motility-altering medications
- Abdominal and pelvic surgery
- Unintentional weight loss, bleeding, anemia, vomiting, fever, nocturnal symptoms, or other reasons for referral
- Stress, trauma, sleep, and autonomic load
Do not diagnose SIBO based on symptoms alone. Bloating is not exclusive to SIBO. The differential diagnosis can include constipation, celiac disease, carbohydrate malabsorption, pancreatic insufficiency, inflammatory disease, pelvic-floor dysfunction, medication effects, and structural pathology.
If you test, know what questions the test can answer
Breath testing may add a piece of information when the probability of SIBO is reasonable and the test result will change the way you manage the patient. It should not be used as a screening test for every patient with random digestive symptoms.
If you order a test, standardize the preparation carefully – note the substrate used, consider transit time and surgical history, and interpret methane separately from hydrogen. Remember that methane positivity is classified as IMO because methanogens may be present in the small intestine or colon.
Match intervention to the patient – and stay inside the evidence
In the episode, I discuss several tools I use in practice, including garlic, oregano, berberine-containing herbs, ginger, digestive support, and a targeted motility product. Those are examples from my clinical experience, not a universal SIBO formula and not proof that a particular product will work “every time.”
Human evidence for specific herbal protocols remains limited and heterogeneous. A widely cited 2014 study of herbal therapy was observational, not a randomized trial of one herb against rifaximin. A 2023 berberine-versus-rifaximin publication described a randomized controlled trial protocol; it did not yet establish comparable efficacy. Product choice, dosing, duration, contraindications, drug interactions, pregnancy status, and the practitioner’s scope all require individual review.
The same caution applies to restrictive diets. A low-FODMAP or specific-carbohydrate approach may reduce fermentable substrate availability and can improve symptoms for some patients, but symptom reduction does not identify or correct the underlying cause. Prolonged dietary restriction can create new nutritional and microbiome problems if it becomes the long-term plan.
Reassess the driver, not just the gas
When the patient shows signs of improvement, do not declare victory and forget the physiology. Go back and revisit motility, thyroid status, medication exposure, meal timing, upper digestion, surgical history, bowel regularity, and nervous-system regulation. If the patient does not improve, reconsider the original diagnosis instead of automatically moving toward an antimicrobial protocol.
That is the difference between ‘treating a test’ and looking deeper at what’s happening to the person sitting in front of you. The breath test is simply one clue. Your job is to determine whether the clue fits – and then ask the much better question: Why did this patient lose the ability to keep the small intestine moving and protected in the first place?
Frequently Asked Questions About SIBO Testing
Is the lactulose breath test accurate for SIBO?
The lactulose breath test has known limitations with regard to accuracy. In a meta-analysis comparing breath tests with small-bowel aspirate culture, pooled sensitivity was about 42% and specificity about 70.6%. Rapid transit can allow lactulose to reach the colon early, where normal colonic fermentation may be misread as small-intestinal overgrowth. It should not be used as a stand-alone diagnosis.
Is a glucose breath test better than a lactulose test?
Glucose breath testing is generally more specific and less affected by early colonic fermentation because glucose is absorbed in the proximal small intestine. However, that also means it may miss overgrowth located farther down the small intestine. If used, the result still needs to be interpreted alongside other symptoms, risk factors, preparation quality, transit, and surgical history.
Can a patient have SIBO with a negative breath test?
Yes, a negative result does not completely exclude SIBO because both glucose and lactulose breath tests have limited sensitivity. It also does not prove that SIBO is present. Persistent digestive symptoms should trigger a broader differential diagnosis and a review of motility, medications, thyroid status, constipation, prior infection, anatomy, malabsorption, and red flags requiring medical evaluation.
Why does SIBO come back after antimicrobials or rifaximin?
Targeted treatment may reduce an overgrowth but may not correct the condition that allowed it to occur in the first place. Impaired motility, post-infectious changes, hypothyroidism, acid suppression, altered anatomy, constipating medications, or other contributing factors may remain. Any recurrence should prompt a reassessment of the original diagnosis and underlying physiology – not just an automatic repeat of the same protocol.
Should practitioners treat SIBO based on symptoms alone?
No. Bloating, abdominal discomfort, diarrhea, and constipation are not unique and specific to SIBO. They can occur with a wide variety of GI and other systemic conditions. The presence of symptoms merely indicate the need for a careful workup, not a diagnosis by themselves. Testing can add context, but neither symptoms nor a breath test should replace a complete history, differential diagnosis, and/or an appropriate referral.
Know What to Do Next
Clinical Academy helps you move beyond collecting more clinical information and start applying it with greater clarity. Inside, I teach the physiology, clinical reasoning, case patterns, and implementation strategies that help you decide what needs your attention first – including a deeper training on SIBO and dysbiosis.
If you want more support connecting the symptoms, history, labs, and underlying physiology, come join us.
Disclaimer/disclosure
This content is for educational purposes only and is intended for wellness practitioners working within the functional medicine and integrative health space. It is not medical advice and does not replace diagnosis, treatment, prescribing decisions, or referral by an appropriately licensed healthcare professional. Practitioners are responsible for applying this information within their legal and professional scope.
The episode includes Ronda Nelson’s personal experience with products from MediHerb, Gaia Herbs, Standard Process, and CellCore. No sponsorship or compensation was received for these mentions.
About Ronda Nelson
Ronda Nelson is a functional medicine educator and practitioner who has trained more than 4,000 wellness practitioners over the past 20+ years. As the founder of Clinical Academy, she helps practitioners strengthen their understanding of physiology, improve their clinical reasoning, and make more confident decisions when working with patients.
Through The Clinical Entrepreneur, Ronda shares clinical insights, case discussions, and practical frameworks that help practitioners recognize patterns, identify contributing factors, and determine what to address next.
Continue Learning
Connect with Ronda
